RxDoctor Payments Data

Irfana Soomro, MD

Nephrology · New York, NYNPI 1134455355

Payments from drug & device makers

What this record shows

That places this record below the midpoint for nephrology clinicians in NY, where the typical reported total is $564.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$123,313in research payments, 2019–2025

Across 123 payments — averaging $1002.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$50K
  • CSL Behring$37K
  • Apellis Pharmaceuticals, Inc.$37K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York

Medicare billing

Part B allowed, 2024
$78,209
Medicare patients
182
Services billed
662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nifedipine ErNifedipine30$651
Losartan Potassium58$431
Hydralazine Hcl38$258
Carvedilol25$216
Isosorbide Mononitrate ErIsosorbide Mononitrate15$120
Amlodipine Besylate18$109
Prednisone39$99
Metoprolol Tartrate24$93
Furosemide36$53

Paid to pharmacies, not to this prescriber.

Other nephrology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →